Document is current

Article History

Received: 16 September 2019

Revised: 23 December 2019

Accepted: 3 January 2020

First Online: 14 January 2020

Compliance with ethical standards

:

: VB serves as Consultant for Spectrum. JNB receives research funding from Angiocrine Bioscience. She performs clinical trial regulatory oversight and is a Consultant for Nohla Therapeutics. She serves as a Consultant and receives research funding from Gamida Cell Ltd. She serves on a review panel for Magenta Therapeutics Inc. SAG receives research funding and serves on advisory boards for Amgen, Celgene, Johnson & Johnson, Takeda, and Actinuum. He is on advisory board for Jazz pharmaceutical, Novartis, KITE, and Spectrum pharmaceutical. He receives research funding from Miltenyi. GAP serves as a Consultant and receives research funding from Merck. MAP reports honoraria from Abbvie, Bellicum, Bristol-Myers Squibb, Incyte, Merck, Novartis, Nektar Therapeutics, and Takeda. He serves on DSMBs for Servier and Medigene, and the scientific advisory boards of MolMed and NexImmune. He has received research support for clinical trials from Incyte, Kite (Gilead) and Miltenyi Biotec. He serves in a volunteer capacity as a member of the Board of Directors of American Society of Blood and Marrow Transplantation (ASBMT) and Be The Match (National Marrow Donor Program, NMDP), as well as on the CIBMTR Advisory Committee and Cellular Immunotherapy Data Resource (CIDR) Oversight Committee. All other authors have no relevant conflicts of interests to disclose.